Jean Jacques Bienaime - Director at BIOMARIN PHARMACEUTICAL INC

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Jean Jacques Bienaime since 12 Aug 2025

Reported holdings for Jean Jacques Bienaime in BIOMARIN PHARMACEUTICAL INC

Form 4 holding Director

BIOMARIN PHARMACEUTICAL INC

Security class
Common Stock
Shares / value
247,333
Estimated value
$19,057,008
Report date
20 May 2024
Price
$77.05
Ownership
Shares held by Jean-Jacques Bienaime Family Trust
Form 4 holding Director

BIOMARIN PHARMACEUTICAL INC

Security class
Common Stock
Shares / value
100
Estimated value
$7,705
Report date
20 May 2024
Price
$77.05
Ownership
Shares held as UTMA custodian for child 1
Form 4 holding Director

BIOMARIN PHARMACEUTICAL INC

Security class
Common Stock
Shares / value
100
Estimated value
$7,705
Report date
20 May 2024
Price
$77.05
Ownership
Shares held as UTMA custodian for child 2
Form 4 holding Director

BIOMARIN PHARMACEUTICAL INC

Security class
Stock Option (Right to Buy Common Stock)
Shares / value
51,000
Estimated value
Report date
10 May 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Jean Jacques Bienaime in BIOMARIN PHARMACEUTICAL INC

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .